Rady Children's Institute Genomic Biorepository
This study, called the Rady Children's Institute Genomic Biorepository, is collecting biological samples like blood, along with genetic information (genomic sequences from DNA and RNA) and health details. The goal is to create a large, standardized resource for future research into genetic diseases, especially those affecting children. Researchers hope this collection will help them better understand the causes and treatments of childhood diseases, improve genetic diagnoses, and develop better ways to manage these conditions. A small portion of the collected samples will undergo genetic analysis right away. This study is open to people of all ages, races, genders, and health statuses, including pregnant women, newborns, and children. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 102,000 participants. It is designed to collect and store biological samples and genetic information for future research.
- What's involved
- You would provide biological samples, such as blood, for storage in the Biorepository. A subset of these samples will undergo genetic analysis.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study plans to collect samples yearly through study completion, estimated to be 40 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Rady Children's Institute Genomic Biorepository
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephen Kingsmore, MD, MSc · PRINCIPAL_INVESTIGATOR · Rady Pediatric Genomics & Systems Medicine Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of samples enrolled per yearYearly through study completion estimated to be 40 years
Establishment of a Biorepository for genomic/precision medicine use in pediatric population. This will make samples available to study rare genetic disorders, screening methods, diagnostic methods, other "omics", and bench research for possible treatments.